A Study of JNT-517 in Participants With Phenylketonuria (PKU)
This research study is for adults (18 and over) with a condition called Phenylketonuria (PKU). We are testing a new tablet medicine, JNT-517, to see if it's safe to use, how well it helps control PKU, and how your body reacts to it. You will either receive the new medicine or a 'dummy' tablet (placebo) without knowing which one, and there's a good chance you'll get the real medicine during the first part of the study. After about six weeks, everyone continuing in the study will receive JNT-517 for many months. Taking part will involve regular check-ups, keeping a food diary, and occasionally collecting urine samples. The study could last for about 400 days in total.
En un coup d'œil
De quoi parle cette étude ?
This study is designed to explore a new tablet medicine called JNT-517 for people living with Phenylketonuria, often called PKU. PKU is a lifelong condition that affects how the body breaks down a substance found in food, called phenylalanine. If not managed properly, high levels of phenylalanine can lead to health problems.
The main aim of this study is to find out if JNT-517 is a safe and effective way to help manage PKU in adults. We also want to understand how your body processes this new medicine. We're especially interested in how it affects your phenylalanine levels. By carefully studying JNT-517, we hope to contribute to new ways of helping people with PKU live healthier lives.
This important stage of research, called Phase 3, means the medicine has already been tested in smaller groups and shown some promise. Now, it's being tested in a larger group of people to confirm these findings and gather more information before it could potentially become widely available.
Points clés
- This study is testing a new PKU tablet, JNT-517, in adults.
- It aims to check the medicine's safety and how well it works.
- You might take JNT-517 or a dummy pill (placebo) at first.
- Participation involves regular check-ups, keeping a food diary, and taking the study medicine twice daily.
- The total study time could be around 400 days.
- Vous pouvez arrêter de participer à tout moment.
Qui peut être éligible ?
To join this study, you need to be an adult (18 years old or over) with a formal diagnosis of PKU. Your phenylalanine levels in your blood also need to be above a certain level during the screening checks.
If you are currently taking other medicines for PKU, such as sapropterin or special amino acid supplements, you might still be able to join, but your dose must have been stable for at least 4 weeks before the study starts and stay stable throughout. If you've been on a medicine called pegvaliase, you would need to have stopped taking it at least 4 weeks before screening.
You also need to be willing and able to stick to a stable PKU diet, and be able to adjust it if needed during the study. There are also specific requirements for women who could become pregnant, including using effective birth control methods.
Cet étude pourrait-elle vous convenir ?
Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.
- Avez-vous 18 ans ou plus ?
- Do you have a diagnosis of PKU?
- Are your phenylalanine levels typically above a certain level?
- Are you able and willing to maintain a stable PKU diet?
- If you might become pregnant, are you willing to use two effective forms of birth control during the study?
En quoi consiste la participation ?
If you decide to take part, you'll first have a screening period that could last up to 35 days. This is to make sure your diet is stable and your phenylalanine levels meet the study's requirements.
After screening, you'll take either JNT-517 or a placebo (dummy pill) twice a day for about 365 days. In the first six weeks, there's a 2 in 3 chance you'll receive JNT-517. After that, if you continue, you will definitely receive JNT-517, but at one of two possible doses, for an additional 46 weeks.
Throughout the study, you'll have regular check-ups, either by visiting a clinic or having a nurse come to your home. You'll also be asked to collect urine samples at home and bring them to the clinic on specific days. For 3 days before each study visit, you'll need to keep a food diary. The total time you could be involved in the study is up to 400 days.
Risques et avantages potentiels
Locations (25)
- University of California Los Angeles (UCLA) School of MedicineCode postal vérifiéLos Angeles, États-Unis· Recrutement
- University of Florida (UF) Health Shands HospitalCode postal vérifiéGainesville, États-Unis· Recrutement
- University of South FloridaCode postal vérifiéTampa, États-Unis· Recrutement
- Ann & Robert H. Lurie Children's Hospital of ChicagoCode postal vérifiéChicago, États-Unis· Recrutement
- Oregon Health and Science UniversityCode postal vérifiéPortland, États-Unis· Recrutement
- University of Pittsburgh Medical Center (UPMC) - Children's Hospital of PittsburghCode postal vérifiéPittsburgh, United States· Recrutement
- Vanderbilt University Medical CenterCode postal vérifiéNashville, United States· Recrutement
- University of Texas SouthwesternCode postal vérifiéDallas, United States· Recrutement
- University of Texas Health (UTHealth) Science Center at HoustonCode postal vérifiéHouston, États-Unis· Recrutement
- Utah Health - The University of Utah HospitalCode postal vérifiéSalt Lake City, États-Unis· Recrutement
- Royal Adelaide HospitalCode postal vérifiéAdelaide, Australia· Recrutement
- Royal Melbourne HospitalCode postal vérifiéParkville, Australie· Recrutement
Questions fréquentes
What is Phenylketonuria (PKU)?
PKU is a genetic condition where your body can't properly process a substance called phenylalanine, which is found in many foods. If not managed, it can build up and cause health problems.
What is JNT-517?
JNT-517 is a new tablet medicine being tested to help control phenylalanine levels in adults with PKU.
Qu'est-ce qu'un 'placebo' ?
A placebo is a 'dummy' tablet that looks like the study medicine but contains no active drug. It helps researchers compare the effects of the new medicine.
Will I know if I'm taking JNT-517 or the placebo?
No, you won't know initially. This is called 'blinding' and helps ensure the study results are fair. Everyone who continues after the first six weeks will receive JNT-517.
Combien de temps durera l'étude ?
Including screening, your participation could last for up to 400 days, which is just over a year.
Comment en savoir plus
Otsuka Call Center
Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.
Intéressé à participer ?
Discussion
Discussion communautaire
Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.